Fernand Bteich, MD, MS (@fernandbteich) header
Fernand Bteich, MD, MS (@fernandbteich) profile picture

Assistant Professor of GI Oncology @EinsteinMed @MontefioreNYC via @slusom and @USJLiban. Views are my own.

New York, NY
Joined November 2009
Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)Photo by Fernand Bteich, MD, MS (@fernandbteich)
Fernand Bteich, MD, MS retweeted
$AMGN Dellphi-305 and $RHHBY Krascendo-1, easily the most impressive datasets of #Esmo26. No contest!
2
9
2
55
12,990
Fernand Bteich, MD, MS retweeted
Preliminary clinical results of QTX3034, an oral G12D-preferring KRAS inhibitor with cetuximab ± mFOLFOX6 in KRASG12D-mCRC #ESMO26 #ESMOAmbassadors 👉ORR: 25% vs 50%, DCR: 75 vs 90% 👉 no new safety signals 🧐Supports the combination with CTx @myESMO @ASCO
17
1
21
2,018
Fernand Bteich, MD, MS retweeted
Steroid free antiemetic regimen in Phase III trial! Phase III (DESCEND, n=644): with NEtupitant/palonosetron (NEPA), a fixed-dose oral com- bination, improves CINV control + olanzapine as the shared backbone, both cutting dexamethasone to a single 6mg dose on day 1 and dropping it entirely were noninferior to standard 4-day DEX for CINV in highly emetogenic chemo. CR (complete response: no emesis, no rescue meds), 0-120h: 72.4% standard vs 72.2% DEX-sparing vs 70.1% DEX-free. Both met noninferiority, confirmed per-protocol. Steroid toxicity (insomnia, agitation, hiccups) dropped significantly in both reduced-DEX arms. @KlugmanMaddie Meng et al, JCO 2026 doi.org/10.1200/JCO.26-01029 #oncology #breastcancer #CINV
22
2
55
4,614
Fernand Bteich, MD, MS retweeted
Superb algorithm by @OncoThor about suggested sequential approaches to systemic therapy for advanced pancreatic neuroendocrine tumors #ASCO26
1
35
60
5,833
Fernand Bteich, MD, MS retweeted
A p-value with a double-digit negative exponent is such an incredible (and richly deserved) flex #ASCO26
15
59
14
444
68,777
Fernand Bteich, MD, MS retweeted
Incredible #ASCO26 moment. Dr. Brian Wolpin, presenter of the daraxonrasib study, received a standing ovation DURING his talk after he stated the survival benefit for PDAC patients. It was sustained. Cheering. I have never see anything like it in the middle of a talk. $RVMD
16
135
31
978
158,205
Fernand Bteich, MD, MS retweeted
Il m’a fait chialer 😭 Wawrinka est le symbole du champion qui n’avait pas sa place parmi les légendes, et qui a déplacé des montagnes et traversé des déserts, pour marquer son sport et aller plus loin que ses rêves. Un exemple. Un mec bien. Simple, vrai, fort. Adieu papy ❤️
13
87
2
970
25,420
Fernand Bteich, MD, MS retweeted
As noted by others, the $RVMD dara mOS in 2nd line PDAC is better than mOS for current first-line regimens.
7
18
3
155
20,538
Fernand Bteich, MD, MS retweeted
I remember years ago in pancreatic cancer trials you were realistically looking for 1 to 2 months improvement in survival (at best) in pancreatic cancer trials. Bravo $RVMD.👏
6
11
199
14,564
Fernand Bteich, MD, MS retweeted
-Papá, ¿tan bueno era Nadal en tierra batida? -Muchísimo, hijo, no se ha visto nunca nada igual. -¿Tan difícil era ganarle un partido? -Los rivales celebraban ganarle un simple punto, hijo. Era una locura.
77
1,199
42
17,228
966,435
Fernand Bteich, MD, MS retweeted
💙 March is Colorectal Cancer Awareness Month. Dr. Fernand Bteich @fernandbteich @MontefioreNYC reviews evolving strategies for KRAS-mutated metastatic CRC, including advances in molecular testing, targeted therapies, and overcoming resistance. 🎥 Watch on #Vumedi: tinyurl.com/59j2ufnp #ColorectalCancer #GIOncology #CancerAwareness #PrecisionOncology
2
2
265
Fernand Bteich, MD, MS retweeted
HISTORIC. 22 year old Carlos Alcaraz defeats 24-time GS champ Novak Djokovic 2-6, 6-2, 6-3, 7-5 to win the #AusOpen for the 1st time and become the YOUNGEST EVER player to complete the career Grand Slam. Already one of the best players ever. What a time to be alive.
131
809
74
5,877
159,603
Fernand Bteich, MD, MS retweeted
Popular art references in Guillermo del Toro’s Frankenstein (2025). Del Toro pulls from classic paintings, gothic illustrations, and early expressionist cinema to shape the Creature’s look and mood. It’s a film stitched together from art history.
2
17
38
8,513
Fernand Bteich, MD, MS retweeted
LBA #STELLAR303 @AnwaarSaeed3 with ⬆️ OS for the combination of Zanzalintinib plus Atezolizumab vs Regorafenib in met #colorectalcancer with HR = 0.80. ⬆️OS in EARLY interim analysis for non-liver mets of 15.9M vs. 12.8M. Published @lancet today. @ExelixisInc #CancerResearch
1
12
1
30
3,395
Fernand Bteich, MD, MS retweeted
STELLAR-303 from Dr. Saeed, zanzalintinib+atezo vs regorafenib in MSS mCRC (>55% liver mets): OS 10.9 vs 9.4 months (HR 0.80, p=0.0045). PFS 3.7 vs 2.0 months. PR rate 4 vs 1%. #ESMO25
2
1
5
2,008
Fernand Bteich, MD, MS retweeted
Sydney McLaughlin-Levrone 🇺🇸 in ONE unforgettable night: • Shattered a 42-year-old Championship Record, the oldest standing at the World Championships • Clocked the fastest women’s 400m time in 40 years • Became the FIRST athlete ever (man or woman) to win world titles in both the 400m & 400mH • Joined the exclusive club of women under 48s — just the 3rd ever! • Set a new American Record • Climbed to No. 2 on the all-time list • Achieved all this in her FIRST complete season at the 400m 🤯 Did we miss anything??🔥
102
1,725
223
11,028
442,932
Fernand Bteich, MD, MS retweeted
For the first time in history $AMD has reached a 50% market share in server CPUs It marks the end of an era for $INTC
86
370
61
2,863
316,466
Fernand Bteich, MD, MS retweeted
not even the Titan Submersible could reach the depths to which Jannik Sinner is digging right now
2
2
30
3,482
Fernand Bteich, MD, MS retweeted
One of the best EVER gets in tennis history.
32
342
48
7,180
729,330
Fernand Bteich, MD, MS retweeted
You don't see survival curves like this often in colorectal cancer, let alone for BRAF mutated CRC. And Median OS: 30.3 vs. 15.1 months. Wow. What a win for our patients! #ASCO25
22
2
91
8,506